HC Wainwright & Co. Reiterates Neutral on Evommune

Evommune, Inc.

Evommune, Inc.

EVMN

0.00

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Evommune (NYSE: EVMN) with a Neutral.